Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Postoperative Formula No. 1 is a traditional Chinese medicine (TCM) decoction primarily used in the management of postoperative recovery, particularly following abdominal or gastrointestinal surgeries. The formula is designed to promote the recovery of gastrointestinal motility and alleviate symptoms such as postoperative ileus, abdominal distension, and pain. While specific compositions can vary by hospital or practitioner, it typically includes herbs known for their prokinetic and anti-inflammatory properties, such as *Magnolia officinalis* (Houpo), *Aurantii Fructus Immaturus* (Zhishi), and *Radix Aucklandiae* (Mu Xiang). The mechanism of action involves the modulation of gastrointestinal hormones (such as motilin and gastrin) and the reduction of inflammatory cytokines that contribute to intestinal paralysis after surgical trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Postoperative Formula No. 1.